Assignee
TRIZELL LTD
GB·15 granted patents·19 pending applications·9 citations·filing 2015–2025
Top patents by PatentIndex Score
34 records- 0186US2025082578A1Viral vector stabilizationTRIZELL LTD·Filed 2024·Application pending·0 cites
- 0284US11261416B2Fixed-bed bioreactor with constant-flow pump / tubing systemTRIZELL LTD·Filed 2017·Granted Mar 1, 2022·2 cites·37 claims
- 0384US11242504B2Aseptic bioreactor sampling systemTRIZELL LTD·Filed 2019·Granted Feb 8, 2022·2 cites·19 claims
- 0482US11311487B2Viral vector stabilizationTRIZELL LTD·Filed 2017·Granted Apr 26, 2022·2 cites·12 claims
- 0581US2024425792A1Fixed-bed bioreactor with constant-flow pump/ tubing systemTRIZELL LTD·Filed 2024·Application pending·0 cites
- 0680US2024117379A1Temperature-responsive virus storage systemTRIZELL LTD·Filed 2023·Application pending·0 cites
- 0780US2023172861A1Viral vector stabilizationTRIZELL LTD·Filed 2022·Application pending·0 cites
- 0879US2024043873A1Temperature-responsive virus storage systemTRIZELL LTD·Filed 2023·Application pending·0 cites
- 0976US12389901B2Temperature-responsive virus storage systemTRIZELL LTD·Filed 2024·Granted Aug 19, 2025·0 cites·5 claims
- 1075US11932843B2Adherent cell culture substrate sampling deviceTRIZELL LTD·Filed 2017·Granted Mar 19, 2024·1 cites·14 claims
- 1175US2025089702A1Temperature-responsive virus storage systemTRIZELL LTD·Filed 2024·Application pending·0 cites
- 1275US2023235341A1Anti-angiogenic gene therapy with soluble vegf receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinomaTRIZELL LTD·Filed 2022·Application pending·0 cites
- 1374US12391911B2Adherent cell culture substrate sampling deviceTRIZELL LTD·Filed 2024·Granted Aug 19, 2025·0 cites·6 claims
- 1474US12116559B2Method of manufacturing a recombinant polypeptideTRIZELL LTD·Filed 2021·Granted Oct 15, 2024·0 cites·6 claims
- 1572US12178865B2CDKN2A companion diagnostic for bladder cancer interferon therapyTRIZELL LTD·Filed 2022·Granted Dec 31, 2024·0 cites·16 claims
- 1672US11547668B2Viral vector stabilizationTRIZELL LTD·Filed 2020·Granted Jan 10, 2023·0 cites·20 claims
- 1772US10829785B2Nucleic acid application primersTRIZELL LTD·Filed 2019·Granted Nov 10, 2020·0 cites·4 claims
- 1871US11781102B2Large-scale PEI-mediated plasmid transfectionTRIZELL LTD·Filed 2017·Granted Oct 10, 2023·2 cites·8 claims
- 1971US2025163519A1Gene therapy vector contamination assayTRIZELL LTD·Filed 2024·Application pending·0 cites
- 2070US12264324B2Viral vector assay and vectorTRIZELL LTD·Filed 2021·Granted Apr 1, 2025·0 cites·17 claims
- 2170US2024247218A1Large scale pei-mediated plasmid transfectionTRIZELL LTD·Filed 2023·Application pending·0 cites
- 2270US2025305000A1Viral vector assay and vectorTRIZELL LTD·Filed 2025·Application pending·0 cites
- 2368US11446249B2Viral vector stabilizationTRIZELL LTD·Filed 2020·Granted Sep 20, 2022·0 cites·8 claims
- 2466US2019275106A1Anti-Angiogenic Gene Therapy KitTRIZELL LTD·Filed 2019·Application pending·0 cites
- 2565US2023175012A1Temperature-responsive virus storage systemTRIZELL LTD·Filed 2021·Application pending·0 cites
- 2660US2019255153A1Interferon TherapyTRIZELL LTD·Filed 2019·Application pending·0 cites
- 2759US12152281B2Gene therapy vector contamination assayTRIZELL LTD·Filed 2019·Granted Nov 26, 2024·0 cites·10 claims
- 2857US11104915B2Viral vector assay and vectorTRIZELL LTD·Filed 2016·Granted Aug 31, 2021·0 cites·4 claims
- 2955US2020360499A1CDKN2a Companion Diagnostic for Bladder Cancer Interferon TherapyTRIZELL LTD·Filed 2018·Application pending·0 cites
- 3054US2023226154A1Compositions and methods for treating cancerTRIZELL LTD·Filed 2021·Application pending·0 cites
- 3151US2019276846A1Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion TimeTRIZELL LTD·Filed 2019·Application pending·0 cites
- 3250US2020222477A1Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive CancerTRIZELL LTD·Filed 2019·Application pending·0 cites
- 3347US2017021039A1Cancer TherapyTRIZELL LTD·Filed 2016·Application pending·0 cites
- 3446US2017051309A1Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion TimeTRIZELL LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TRIZELL LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →